Developing Multi-Core Silicon-Based Quantum Processors

The project aims to develop a scalable FDSOI-based quantum processor demonstrator with a 4X4 multi-core architecture to bridge the gap between semiconductor techniques and quantum computing needs.

Subsidie
€ 2.440.870
2024

Projectdetails

Introduction

Silicon technology was the key to transforming classical computing into a massive industry. Could it play a similar role in quantum computing? Silicon qubits have several attractive features and can rely on a mature industry that has already mastered the intricacies of scaling.

Challenges in Commercialization

However, while scientific advances in silicon qubit technology have been encouraging, progress has been modest on the commercial front. This is the consequence of a rift between the techniques of the semiconductor industry and the requirements of quantum computers.

Siquance's Approach

At Siquance, we close this gap thanks to a ground-breaking semiconductor approach: Fully Depleted Silicon On Insulator (FDSOI) technology. FDSOI technology enables the fabrication of high-quality qubits in a scalable and reproducible manner.

Project Goals

Now, we advance these developments to the market. This project aims at delivering an FDSOI-based quantum processor demonstrator with a novel 4X4 multi-core architecture.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.440.870
Totale projectbegroting€ 2.440.870

Tijdlijn

Startdatum1-1-2024
Einddatum30-6-2026
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • QUOBLYpenvoerder

Land(en)

France

Vergelijkbare projecten binnen EIC Transition

EIC Transition

Targeting cardiac fibrosis with next generation RNA therapeutics

FIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness.

€ 2.499.482
EIC Transition

automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS

The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.

€ 2.497.750
EIC Transition

Predictive REagent-Antibody Replacement Technology stage 2-Translation

PRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment.

€ 800.000
EIC Transition

Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stage

Developing a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships.

€ 2.499.810

Vergelijkbare projecten uit andere regelingen

ERC STG

Spins Interfaced with Light for Quantum Silicon technologies

The SILEQS project aims to demonstrate indistinguishable single-photon emission and spin control from silicon defects to enable scalable quantum communication technologies.

€ 1.500.000
EIC Pathfinder

ENABLING NEW QUANTUM FRONTIERS WITH SPIN ACOUSTICS IN SILICON

This project aims to develop a scalable silicon-based quantum information platform by enhancing qubit control, readout, and coupling mechanisms, fostering collaboration across Europe for advanced quantum computing.

€ 3.235.322
EIC Pathfinder

Quantum technology with a spin-photon architecture for thousand-qubit chipsets at telecom wavelengths

QuSPARC aims to develop wafer-scale processes for thousands of high-quality qubit sites in silicon carbide, advancing scalable quantum information devices for million-qubit systems.

€ 2.992.374
EIC Accelerator

Democratizing quantum computing with 3D scalable and customizable quantum processors:

The project aims to revolutionize quantum computing by developing affordable, customizable, and scalable QPUs using innovative technologies, enabling faster access to high-capacity quantum processors.

€ 2.499.700